LogMARmedian ± IQR | P-Value | ||
---|---|---|---|
absent | present | ||
Peripheral involvement | 0.10 ± 0.48 | 0.48 ± 1.11 | 0.002* |
Isolated peripheral involvement | 0.30 ± 0.90 | 0.50 ± 0.64 | 0.866 |
Peripheral and posterior involvement | 0.14 ± 0.63 | 0.48 ± 1.12 | 0.007* |
Posterior pole involvement | 0.10 ± 0.48 | 0.48 ± 0.82 | < 0.001* |
Diffuse posterior pole leakage | 0.10 ± 0.60 | 0.48 ± 1.84 | 0.003* |
Severe Posterior pole leakage | 0.18 ± 0.50 | 1.15 ± 1.82 | < 0.001* |
Peripheral capillary nonperfusion | 0.3 ± 0.98 | 0.4 ± 0.73 | 0.280 |
Vascular anastomosis | 0.18 ± 0.64 | 0.94 ± 0.6 | 0.03* |
Neovascularization elsewhere | 0.4 ± 0.9 | 0.2 ± 0.38 | 0.992 |
Neovascularization at disc | 0.4 ± 0.9 | 0.39 ± 1.69 | 0.632 |
Branch retinal vein occlusion | 0.4 ± 0.9 | 1.05 ± a | 0.731 |
Central retinal vein occlusion | 0.35 ± 0.81 | 2.3 ± a | 0.326 |
Central retinal artery occlusion | 0.3 ± 0.78 | 2.15 ± a | 0.037* |
Cystoid macular edema | 0.4 ± 0.9 | 0.29 ± 0.36 | 0.600 |
Macular ischemia | 0.18 ± 0.5 | 1.0 ± 1.45 | < 0.001* |
Arterial narrowing | 0.18 ± 0.38 | 1.65 ± 1.3 | < 0.001* |